Skip to main navigation Skip to search Skip to main content

Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis with Mildly Decreased and Normal Lung Function: A Real-Life Observational Study

  • Karin Yaacoby-Bianu
  • , Adi Dagan
  • , Malena Cohen-Cymberknoh
  • , Lior Tsviban
  • , Michal Gur
  • , Inbal Golan-Tripto
  • , Micha Aviram
  • , Nili Stein
  • , Michal Shteinberg
  • , Eitan Kerem
  • , Galit Livnat*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish
Pages (from-to)1620-1623
Number of pages4
JournalAnnals of the American Thoracic Society
Volume21
Issue number11
DOIs
StatePublished - Nov 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this